Sanders Places Hold on Obama’s Nominee for FDA Commissioner

January 27, 2016

In September 2015, President Obama nominated Robert Califf, MD, a world renowned cardiologist and clinical trial expert, to serve as the next FDA Commissioner. Following his nomination, Dr. Califf received the overwhelming support of a large number of Senators. However, there were also a number of Senators who opposed his nomination, questioning his close ties to pharmaceutical companies and voicing concern over the impact of funding he received for research during his time at Duke University.

Despite receiving some criticism, the US Senate Committee on Health, Education, Labor, & Pensions (HELP) announced its approval of Dr. Califf on January 12, 2016.  Presidential candidate Senator Bernie Sanders (I – VT), a member of the HELP committee and one of Califf’s opponents, was unable to attend this meeting due to his campaign.

On Tuesday, January26, Sanders joined with Senator Edward J. Markey (D – MA) to announce that they are placing a hold on Dr. Califf to serve as comissioner of the FDA. In a recent press release, Sanders provided his reasoning, stating that it is “because of his close ties to the pharmaceutical industry and lack of commitment to lowering drug prices.”

Although we thought we were nearing the end of this process, it appears as though that is not going to be the case. It will be very interesting to watch as this continues to unfold.




Agency Alerts General Regulatory

January 27, 2016

Last Stop: President Obama – 21st Century Cures Bill Passes Through the Senate and Heads to Obama for Signature

After passing through the House of Representatives with an extraordinary amount of support last week, the 21st Century Cures Act headed to the Senate on Monday, December 5th. On Wednesday, December...

Read More
Agency Alerts General Regulatory

January 27, 2016

Bill to Encourage Development of Zika Vaccine Awaits President Obama’s Signature

On Tuesday, April 12, the US House of Representatives approved a bipartisan bill to speed the development of a treatment for the Zika virus.  The bill was introduced by US Rep. G. K. Butterfield (D –...

Read More
Agency Alerts General Regulatory

January 27, 2016

New Law Provides More Certainty on When Controlled Substances are Officially Approved

President Obama recently signed the Improving Regulatory Transparency for New Medical Therapies Act into law. The law clarifies when controlled substances are officially approved by the FDA,...

Read More